Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study

Price, M. J., Boutis, L., Kirtane, A. J., Chetcuti, S., Poliačiková, P., Dens, J., Attubato, M., Wang, Y., Hu, P., Spriggs, D., Krasnow, J., Chatzizisis, Y., Aminian, A., Caputo, R., Shah, A., Dauler, M., Ibrahim, S., Lung, T.-H., & Mehran, R. (2023). Three-Year Outcomes After Bifurcation Stenting With Zotarolimus-Eluting Stents: Final Results From the RESOLUTE ONYX Postapproval Study. Journal of the Society for Cardiovascular Angiography & Interventions, 2(6), 101116. https://doi.org/10.1016/j.jscai.2023.101116
Authors:
Matthew J. Price
Loukas Boutis
Ajay J. Kirtane
Stanley Chetcuti
Petra Poliačiková
Joseph Dens
Michael Attubato
Yale Wang
Patrick Hu
Douglas Spriggs
Joshua Krasnow
Yiannis Chatzizisis
Adel Aminian
Ronald Caputo
Alpesh Shah
Michelle Dauler
Sherif Ibrahim
Te-Hsin Lung
Roxana Mehran
Affiliated Authors:
Ajay J. Kirtane
Author Keywords:
bifurcation
drug-eluting stent
percutaneous coronary intervention
zotarolimus
Publication Type:
Article
Unique ID:
10.1016/j.jscai.2023.101116
Publication Date:
Data Source:
Scopus

Record Created: